Patents by Inventor Ray A. Ollson

Ray A. Ollson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
    Patent number: 7019027
    Abstract: The present invention relates to a compound of formula (I): wherein: R3 is selected from the group consisting of 1-napthyl, 2-napthyl and cycloalkylphenyl; and R4 and R5 taken together form a ring having from 5 to 10 carbon atoms. Additionally, the invention provides a therapeutic method for preventing or treating a pathological condition or symptom in a mammal subject, such as a human, wherein increased angiogenesis is desired, comprising administering to a mammal in need of such therapy an effective amount of the aforementioned thiophene selective adenosine A1 allosteric enhancer.
    Type: Grant
    Filed: March 23, 2004
    Date of Patent: March 28, 2006
    Inventors: Joel M. Linden, Ray A. Ollson, Peter J. Scammells
  • 2-Amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
    Publication number: 20040180948
    Abstract: The present invention relates to a compound of formula (I): 1
    Type: Application
    Filed: March 23, 2004
    Publication date: September 16, 2004
    Inventors: Joel M. Linden, Ray A. Ollson, Peter J. Scammells
  • 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
    Patent number: 6713638
    Abstract: The present invention relates to a compound of formula (I): wherein: R3 is selected from the group consisting of 1-napthyl, 2-napthyl and cycloalkylphenyl; and R4 and R5 taken together form a ring having from 5 to 10 carbon atoms. Additionally, the invention provides a therapeutic method for preventing or treating a pathological condition or symptom in a mammal subject, such as a human, wherein increased angiogenesis is desired, comprising administering to a mammal in need of such therapy an effective amount of the aforementioned thiophene selective adenosine A1 allosteric enhancer.
    Type: Grant
    Filed: May 20, 2002
    Date of Patent: March 30, 2004
    Inventors: Joel M. Linden, Ray A. Ollson, Peter J. Scammells
  • 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
    Publication number: 20030078248
    Abstract: The present invention relates to a compound of formula (I): 1
    Type: Application
    Filed: May 20, 2002
    Publication date: April 24, 2003
    Inventors: Joel M. Linden, Ray A. Ollson, Peter J. Scammells